Manzo Pharmaceuticals, Inc.
MNZO · OTC
12/31/2015 | 12/31/2014 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | – | -$4,150 | -$3,953 |
| Dep. & Amort. | – | – | $0 | $0 |
| Deferred Tax | – | – | $0 | $0 |
| Stock-Based Comp. | – | – | $0 | $0 |
| Change in WC | – | – | $3,090 | $789 |
| Other Non-Cash | – | – | -$49 | $1,581 |
| Operating Cash Flow | – | – | -$1,109 | -$1,583 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | – | -$2 | -$3 |
| Net Acquisitions | – | – | $0 | $0 |
| Inv. Purchases | – | – | $0 | $0 |
| Inv. Sales/Matur. | – | – | $0 | $0 |
| Other Inv. Act. | – | – | $0 | $0 |
| Investing Cash Flow | – | – | -$2 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | – | $1,118 | $840 |
| Stock Issued | – | – | $0 | $0 |
| Stock Repurch. | – | – | $0 | $0 |
| Dividends Paid | – | – | $0 | $0 |
| Other Fin. Act. | – | – | $0 | $0 |
| Financing Cash Flow | – | – | $1,118 | $840 |
| Forex Effect | – | – | -$9 | -$11 |
| Net Chg. in Cash | – | – | -$2 | -$757 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | – | $12 | $769 |
| End Cash | – | – | $10 | $12 |
| Free Cash Flow | – | – | -$1,111 | -$1,586 |